月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE(每份年报一根整柱,柱宽 = 生效期:报告期 + 4 个月起)
加载中…
获利能力 Profitability (单位:美元)
| 指标 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | - | 28.02% | 32.54% | 57.23% | 1150.48% | -230.72% | -323.95% | -1185.28% | 509.31% | 143.73% | 112.68% | 104.58% | 80.74% | 57.66% | 66.20% | 35.14% | 38.34% |
| 总资产收益率(ROA) | - | 16.15% | 15.26% | 13.14% | 13.02% | 14.51% | 15.36% | 24.52% | 23.34% | 25.35% | 30.56% | 24.72% | 25.92% | 26.96% | 31.62% | 16.11% | 17.92% |
| 毛利率 | 53.05% | 54.06% | 54.91% | 54.93% | 55.58% | 54.94% | 55.73% | 56.10% | 56.73% | 58.04% | 58.76% | 59.52% | 59.82% | 61.04% | 61.80% | 62.53% | 63.71% |
| 净利率 | 13.27% | 13.79% | 13.64% | 12.25% | 11.99% | 12.51% | 13.37% | 17.04% | 17.77% | 21.51% | 23.17% | 20.17% | 23.08% | 22.78% | 24.62% | 25.46% | 26.17% |
| 每股收益(EPS) | 2.85 | 3.24 | 1.77 | 1.82 | 2.07 | 2.47 | 3.00 | 4.34 | 4.97 | 6.82 | 8.74 | 8.12 | 10.17 | 10.77 | 13.17 | 6.64 | 7.78 |
财务结构 Financial Structure
| 指标 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 20.30% | 22.68% | 23.30% | 8.75% | 10.12% | 10.95% | 8.05% | 4.93% | 16.73% | 5.93% | 4.10% | 13.92% | 8.75% | 5.37% | 4.94% | 5.72% |
| 负债占总资产比率 | - | 42.35% | 57.89% | 91.50% | 105.69% | 107.07% | 103.14% | 100.60% | 90.30% | 72.42% | 71.69% | 77.84% | 54.46% | 51.56% | 52.09% | 56.20% | 53.15% |
经营能力 Operating Capability
| 指标 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 9.35 | 8.71 | 9.75 | 8.51 | 8.68 | 8.39 | 8.89 | 8.94 | 8.17 | 8.73 | 8.41 | 8.00 | 8.23 | 7.79 | 3.76 | 3.76 |
| 平均收现日数 | - | 39 天 | 42 天 | 37 天 | 43 天 | 42 天 | 43 天 | 41 天 | 41 天 | 45 天 | 42 天 | 43 天 | 46 天 | 44 天 | 47 天 | 97 天 | 97 天 |
| 固定资产周转率(次) | - | 0.1896 | 0.2042 | 0.2043 | 0.2079 | 0.2013 | 0.1925 | 0.1976 | 0.2218 | 0.2051 | 0.1828 | 0.1929 | 0.1918 | 0.1830 | 0.1737 | 0.3509 | 0.3110 |
| 总资产周转率 | - | 117.19% | 111.91% | 107.34% | 108.60% | 115.99% | 114.92% | 143.96% | 131.35% | 117.96% | 131.93% | 122.59% | 112.30% | 118.34% | 128.44% | 63.28% | 68.48% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 2.24 | 2.79 | 3.23 | 1.29 | 1.55 | 1.88 | 1.24 | 0.90 | 3.84 | 1.44 | 1.13 | 4.54 | 2.88 | 1.80 | 1.65 | 1.97 |
| 净利润 | 1.62 | 1.78 | 1.88 | 1.82 | 1.92 | 2.22 | 2.63 | 3.77 | 4.28 | 5.82 | 7.45 | 6.79 | 8.45 | 8.88 | 10.59 | 5.37 | 6.17 |
| 经营活动现金流量 | 2.18 | 2.22 | 2.46 | 2.36 | 2.22 | 3.39 | 3.73 | 4.00 | 4.59 | 6.48 | 7.56 | 5.43 | 9.07 | 9.29 | 11.82 | 4.24 | 6.13 |
| 投资活动现金流量 | -0.94 | -0.58 | -0.86 | -0.80 | -3.08 | -0.91 | -1.39 | 1.39 | -2.06 | -1.09 | -2.93 | -1.95 | -1.25 | -2.07 | -1.36 | -0.63 | -0.59 |
| 筹资活动现金流量 | -0.98 | -1.25 | -1.02 | -1.03 | -1.01 | -2.22 | -2.08 | -5.98 | -2.86 | -2.48 | -6.97 | -3.71 | -4.42 | -8.78 | -11.65 | -4.96 | -5.37 |
| 净现金流量 | 0.27 | 0.40 | 0.55 | 0.43 | -1.94 | 0.26 | 0.33 | -0.64 | -0.33 | 2.94 | -2.39 | -0.32 | 3.41 | -1.66 | -1.08 | -1.24 | 0.17 |
右侧两列为报告期累计口径同比(左:去年同期同一期次,右:最近一期季报,年报期次已在左侧列展示);周转率类指标为报告期累计值,未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD